Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8114 Cr | ₹830 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 31% |
| Expense Ratio | 1.82 | 2.27 |
| Manager | Sailesh Raj Bhan | Dhaval Joshi |
| ISIN Code | INF204K01968 | INF209KB1N91 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | 1.8% | 0.52% |
| 6 Month | 4.37% | 5.18% |
| 1 Year | -0.63% | -1.37% |
| 3 Year | 20.52% | 20.28% |
| 5 Year | 17.79% | 15.82% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | 1.5% | 2.09% |
| 1 Year | 7.15% | 7.34% |
| 3 Year | 18.93% | 18.73% |
| 5 Year | 17.25% | 16.38% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 16.99% | 23.67% |
| 3 Year | 20.8% | 17.01% |
| 5 Year | 20.54% | 21.83% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 15.24% | 16.01% |
| Sharp | 0.90% | 0.85% |
| Beta | 0.91% | 0.96% |
| Alpha | -0.55% | -1.37% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Dhaval Joshi |
| Total AUM | ₹96086 Cr | ₹361932 Cr |
| Funds Managed | 5 | 55 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 1.52 | 4.88 |
| Large Cap | 33.27 | 25.69 |
| Mid Cap | 33.86 | 41.06 |
| Small Cap | 31.35 | 28.36 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 0.53 | 1.66 |
| Healthcare | 99.47 | 97.35 |
| Basic Materials | - | 0.99 |
Top Comparisons
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns%
Sundaram Equity Savings Fund (Formerly Known as Principal Equity Savings Fund) - Direct Plan - Growth Option
3Y Returns%
Franklin India Large & Mid Cap Fund - Growth Plan
3Y Returns17.5%
INVESCO INDIA LARGE & MID CAP FUND - Growth
3Y Returns24.04%
ITI ELSS Tax Saver Fund Regular - Growth
3Y Returns19.83%
ICICI Prudential ELSS Tax Saver Fund (Tax Saving) - Growth
3Y Returns15.82%
Aditya Birla Sun Life Money Manager Fund - Growth
3Y Returns7.59%
Aditya Birla Sun Life Money Manager Fund - Growth
3Y Returns7.59%